Notch signaling pathway has been shown to play essential roles in T lymphocyte development. Activation of Notch requires a sequential proteolytic cleavage, which converts Notch from the fulllength membrane-bound form to a transcriptionally active intracellular fragment. Studies in Drosophila showed that Kuzbanian (Kuz) is responsible for the enzymatic cleavage of extracellular S2 site upon Notch binding to its ligand Delta. Both a disintegrin and metalloprotease (ADAM) 10 and ADAM17, members of the ADAM family metalloproteases, have been indicated as the mammalian counterpart of Kuz in activating Notch in mammals. Here, we investigated functions of ADAM10 in Notch signaling during thymocyte development. We show that conditional disruption of the Adam10 gene in mouse thymocytes results in a developmental defect similar to the phenotypes previously described for T lineage-specific disruption of Notch1. We further show that the activation of Notch1 and its downstream target genes Deltex-1 and Pre-Ta are impaired in Adam10-deficient thymocytes. Our study demonstrates a T cell intrinsic role for Adam10 in activation of Notch1 during thymocyte development.
Introduction
The development of T lymphoid lineage follows a series of differentiation and selection events prior to their exit of the thymus. The canonical differentiation pathway is operationally divided into CD4CD8 double-negative (DN), CD4CD8 double-positive (DP) and CD4 or CD8 singlepositive (SP) stages. TCR gene rearrangement starts at the DN stage where cell fates are further divided into the ab or cd lineage due to expression and selection of the appropriate TCR chains (1) . While a small fraction of DN cells choose the cd fate, most DN cells enter the ab lineage upon successful rearrangement and expression of a functional TCRb chain (2) . These TCRb-expressing cells quickly expand and differentiate into the DP stage where TCRa gene rearrangement occurs. DP cells are further selected for expression of a functional abTCR before differentiating into the CD4 helper or CD8 cytotoxic SP stage. T cells expressing strong autoreactive TCR are eliminated through negative selection whereas the remaining mature CD4 and CD8 T cells leave thymus and enter peripheral lymphoid tissues.
Notch signals play critical roles in several stages of T cell development (3), including T cell-fate determination, TCRb gene rearrangement, DN thymocyte differentiation, DP thymocyte survival, CD4/CD8 differentiation in the thymus and later on T h 1/T h 2 differentiation in the periphery (4) . Notch receptor is a transmembrane protein, which is activated upon interaction with its ligand such as Delta-like and Jagged expressed on neighboring cells (5) . The ligand binding triggers a series of proteolytic cleavage events, leading to the production of the transcriptionally active intracellular domain of Notch (ICN) (6) . ICN enters nucleus to form a transcription complex with CBF-1, Suppressor of hairless and Lag-1 and together they activate Notch target genes. An important step in Notch activation is the cleavage of extracellular domain of Notch at the S2 site (7, 8) . Both genetic and biochemical studies in Drosophila have demonstrated that a metalloprotease encoded by kuzbanian (kuz) is directly responsible for S2 cleavage and activation of Notch. In mammals, this cleavage is accomplished by one of a disintegrin and metalloprotease (ADAM) family members. Both ADAM10 and ADAM17 are reported as the potential sheddase to cleave Notch at the S2 site (9) (10) (11) . Which Adam gene is responsible for activation of Notch signals in T cell development has not been firmly defined.
The specific cleavage of Notch S2 site by ADAM17 has been shown in cultured monocytic precursor cells (9, 10) . However, the phenotype of Notch1 knockout mice resembles Adam10 rather than Adam17 knockout mice (12, 13) . Because Adam10 knockout resulted in embryonic lethality, further genetic study of relationship between Adam10 and different Notch genes in the lymphoid system was not possible with these conventional knockout mice. A role for Adam10 in regulating T cell development has been suggested only recently by the study of transgenic mice expressing a dominant-negative form of ADAM10 (14) . The developmental defects revealed in the transgenic mice were very similar to the reported phenotypes of conditional disruption of Notch1 (14-16). However, it is not known whether ADAM10 is the one and only protease inhibited by the dominant-negative transgene. In fact, a recent study has demonstrated a T cell extrinsic role for Adam17 in regulating T cell development even though Adam17 is expressed in both developing T cells and thymic stromal cells (17) . To explicitly define Adam10 function in T cell development, we generated a conditional knockout allele of Adam10 and used it to test function of Adam10 in T cell development. Our study establishes a T cell intrinsic role for ADAM10 in activation of the Notch1 pathway during T cell development.
Methods

Establishment of Adam10 conditional deletion allele
Genomic DNA fragments surrounding exon 3 of the Adam10 gene were isolated from a k-phage library (Stratagene). The 5396-bp XbaI-KpnI fragment of intron 3, the 576-bp PstIXbaI fragment containing exon 3 and the 1473-bp StuI-XbaI fragment of intron 2 from the Adam10 gene were used as the long arm, center fragment and short arm in the targeting vector, respectively. Compared with the wild-type genomic DNA, a 337-bp XbaI-PstI fragment in intron 2 was deleted in the final construct. The targeting construct was introduced into W4/129S6 embryonic stem cells (Taconic) by electroporation. PCR screen with primers KOMOCK (F) and MORC2-2 (Table 1) 
FACS analysis and cell sorting
Single-cell suspensions from the thymus, spleen or lymph nodes were prepared in pre-cooled PBS supplemented with 5% bovine calf serum and stained for four-color FACS analysis. Data were collected and analyzed with CellQuest on a FACSCalibur (BD Biosciences). Cell sorting was performed on a FACSVintageSE (BD Biosciences). Antibodies used were FITC-conjugated anti-CD4 (Caltag and eBioscience), PE-conjugated anti-CD8b (Caltag), APC-conjugated anti-TCRb (Caltag), FITC-conjugated anti-TCRgd (Caltag), PE-conjugated anti-CD19 (Caltag), PE-conjugated anti-TCRb (eBioscience), PE CY5-conjugated anti-CD4 (Caltag), PE CY5-conjugated anti-CD8 (eBioscience), FITC-conjugated anti-CD44 (Caltag), APC-conjugated anti-CD8b (Caltag), APC-conjugated anti-CD25 (Caltag) and PE CY5-conjugated anti-B220 (Caltag). DN, DP, CD4 or CD8 SP thymocytes were sorted after exclusion of cells stained positive for 7-amino actinomycin D (7AAD, Invitrogen) and B220. Intracellular staining was done by 2% PFA fixation followed by permeabilizing in 0.5% saponin.
Western blotting
Thymus was dispersed into single-cell suspension in precooled PBS and 5% bovine calf serum, incubated on ice for 30 s, passed through a 200-mesh size filter and spun at 4°C. Cell pellets were then homogenized in 13 RIPA buffer (Santa Cruz Biotechnology) and 13 complete protease inhibitor mixture (Roche Biochemical Laboratories). Extracted proteins were quantified with a BCA TM Protein Assay Kit (Pierce). Forty micrograms of protein per sample was used for electrophoresis on 8% SDS-PAGE gel and transferred onto polyvinylidene difluoride membrane (Millipore). Rabbit anti-mouse cleaved Notch1 antibody (1/1000; 2421s; Cell Signaling Technology) and bovine anti-rabbit HRP antibody (1/2000; Sc-2370; Santa Cruz Biotechnology) were used to detect Notch proteins. Goat anti-mouse actin antibody (1/400; Sc-1615; Santa Cruz Biotechnology) and bovine anti-goat HRP antibody (1/2000; Sc-2350; Santa Cruz Biotechnology) were used to detect actin. Enhanced chemiluminescence reagent (Pierce) was applied after antibody incubation in both experiments. For stripping, the membrane was sequentially incubated in TBST, H 2 O, 0.2 M NaOH, H 2 O 
and TBST at room temperature for 5 min each step. The stripped membrane was blocked with TBST-5% milk for 3 h at room temperature before additional round of blotting. Table 1 .
Real-time PCR assay for gene expression
Statistics P values were obtained with two-tailed unpaired Student's t-test on Prism 4 (GraphPad Software).
Results
Thymocyte-specific deletion of the Adam10 gene
To investigate the function of the Adam10 gene in thymocyte development, we established an Adam10 conditional deletion mouse strain. The floxed Adam10 allele, named Adam10 loxP , contains two loxP sites in cis orientation flanking the third exon of Adam10 (Fig. 1A) . Cre-mediated Adam10 deletion in germ line resulted in embryonic lethality around the same stage as a previous report (13) of the germ line knockout of Adam10 (data not shown). However, the Adam10 loxP/loxP homozygous and the Adam10 loxP/À hemizygous mice are completely viable and fertile. A mouse line carrying the Lck-Cre transgene (18) was used to delete the genomic sequence between the two loxP sites in a T cellspecific manner. A PCR-based assay was used to evaluate the timing and efficiency of Adam10 deletion on FACSsorted thymocytes (Fig. 1B) . Three primers were used to simultaneously amplify the floxed and the deleted allele in the same PCR. Cre-mediated deletion was detected as early as the DN stage. The deleted allele became the major product in the DP cells, indicating that the majority of DP cells have lost the floxed allele. Because the size of the PCR product from the deletion allele is significantly larger than the floxed allele in this competitive PCR assay, the relative frequency of deleted allele is most likely an under estimation. No Adam10 loxP allele can be detected in CD4 or CD8 SP cells by this PCR assay. Real-time RT-PCR analysis was used to further assess the extent of Adam10 deletion in total thymocytes (Fig. 1C) . The exon 3 containing transcript of Adam10 in Adam10 loxP/loxP Lck-Cre mice was only 8% of Adam10 loxP/loxP littermates, confirming that Adam10 was successfully disrupted in most thymocytes. Meanwhile, ADAM17 expression was not significantly altered in Adam10 loxP/loxP Lck-Cre mice (Fig. 1D) . 
Impaired thymocyte development in Adam10 conditional knockout mice
Function of the Adam10 gene in T development was evaluated by FACS analysis of lymphocytes isolated from thymus, spleen and lymph nodes ( Fig. 2A) . Overall, the total thymic cellularity is decreased ;2-to 3-fold in Adam10 loxP/loxP LckCre mice (Fig. 2B ). This decrease is primarily due to a reduction in the number of DP cells (Fig. 2C) . The number of CD4 SP cells also showed a moderate decrease whereas numbers of CD8 SP cells and cd T cells in the thymus are not affected by Adam10 disruption. To further enhance the efficiency of deletion, we also generated and tested the Adam10 loxP/À Lck-Cre mice, in which Cre-mediated deletion of the single Adam10 loxP allele on the hemizygous background is sufficient to induce complete inactivation of Adam10. The phenotypic defects resulting from this deletion strategy is similar to those obtained with Adam10 loxP/loxP Lck-Cre mice (Fig. 2B and C) , confirming that the impaired thymocyte development is due to a significant loss of ADAM10. These results resemble the previously described Notch1 mutant mice, which carry homozygous Notch1 floxed allele and Lck-Cre transgene (15).
TCRb expression is not significantly affected after Adam10 deletion
Notch signals have been shown to play a particularly important role in supporting ab lineage development among T cell progenitors undergoing TCRb rearrangement (2, 15) . To further explore whether reduced number of DP cells is due to any impairment of TCRb expression, we evaluated intracellular TCRb (icTCRb) expression in DN3 cells (Fig. 3) . The percentage of icTCRb-positive DN3 cells was found slightly increased from 29.4% (62.1%) for the wild-type controls to 40.12% (61.9%) for the mutant mice ( Fig. 3B and C) . The absolute numbers of DN3 cells for both icTCRb-positive and -negative fractions were decreased in Adam10 conditional knockout mice (Fig. 3D) . The level of icTCRb expression in DN4 and DP cells was found indistinguishable between Adam10 mutant and Adam10 wild-type littermate controls (Fig. 3B ). While this assay is not sensitive enough to detect any subtle changes in the rearrangement status and repertoire usage involving the TCRb locus, the result suggests that the reduced thymic cellularity, including DN3, DP and SP cells, in Adam10 conditional knockout mice is unlikely due to lack of TCRb rearrangement and expression.
Failure of Notch activation in Adam10 conditional knockout mice
To explore whether the impaired thymocyte development in Adam10 conditional knockout mice is due to a defect in Notch1 activation, we examined the Notch signaling pathway. A key step in Notch activation is the generation of ICN, the activated form of Notch (19) . An antibody specific for ICN (20) was used in western analysis of protein extracts from total thymocytes. ICN was readily detected in Adam10 loxP/loxP control mice and was significantly reduced in Adam10 loxP/loxP Lck-Cre mice (Fig. 4A) . Real-time RT-PCR analysis showed that the RNA level of Notch1 is not affected by Adam10 knockout (Fig. 4B) . Together, these results indicate that Adam10 knockout directly affect the Notch1 proteolysis rather than expression. To further assess Notch signaling pathway in Adam10 conditional knockout mice, we evaluated Notch1 target genes in thymocytes. Hes1, Deltex-1 and pre-Ta have been shown to be directly regulated by Notch1 in thymocyte development (21) (22) (23) . Real-time RT-PCR analysis of total thymocytes showed that the transcription level of Deltex-1 was down-regulated in the mutant mice (Fig. 4C) . The average mRNA level of Hes1 and pre-Ta in total thymocytes of mutant mice was not significantly altered or slightly reduced, respectively. Recent reports identified a role for Notch1 in regulating Gata3 during T h 1/T h 2 differentiation (4, 24) . Given that Gata3 is also involved in CD4 SP cell development in the thymus, we examined Gata3 expression in Adam10 conditional knockout mice. Real-time RT-PCR analysis of total thymocyte RNA showed that Gata3 expression is not affected by Adam10 disruption (Fig. 4C) , suggesting that Gata3 expression in thymocytes is not dependent on Notch signals.
Discussion
Although both ADAM10 and ADAM17 are implicated as the metalloprotease responsible for activation of Notch, which one is responsible for activation of Notch in thymocyte development remained as an outstanding issue. The conditional Adam10 knockout study described here supports the idea that ADAM10 is a critical player in regulating Notch function during T cell development. Prior to the current work, the only data available to address this issue came from the transgenic study using a dominant-negative form of ADAM10 in thymocytes (14) . Mice expressing the dominantnegative form of ADAM10 under the control of the Lckproximal promoter exhibited a phenotype similar to Notch1 conditional knockout induced by the same Lck-proximal promoter (15) . The overall loss of DP and SP thymocytes observed in our Adam10 conditional knockout mice are consistent with findings from these earlier reports. One noticeable difference came from the analysis of icTCRb expression in DN3 cells. While conditional Notch1 knockout resulted a reduced frequency of icTCRb expression among DN3 cells (15), we find that the frequency of icTCRb expression is slightly increased in DN3 thymocytes. Therefore, it is possible that ADAM17 which is preferentially expressed in DN thymocytes and thymic stromal cells (17) may play a compensatory role in activating Notch1 at the early stage of T cell development.
The various degrees of changes in expression of these Notch target genes could be partially explained by their expression patterns during T cell development and the Cre line used in this study. Hes1 and pre-Ta are expressed primarily in DN stage and dramatically down-regulated in DP and SP stage whereas Deltex-1 is expressed in the DN stage, moderately down-regulated in DP and up-regulated again in SP stage (25) . Analysis of Adam10 deletion among sorted thymocytes showed that efficient deletion was not achieved until DP stage of development in the Lck-Cre mice. Therefore, the Notch signals may not be effectively disrupted until the DP stage in Lck-Cre-mediated conditional knockout system. In fact, the lack of significant change in pre-Ta expression is also reported in the analysis of Notch1 conditional knockout mice (15) . An understanding of Adam10 function in T lineage commitment may require the use of Cre transgene which drives Cre expression earlier than Lck-Cre. Our attempt to delete Adam10 in hematopoietic progenitors with a Tie2-Cre transgene (26) resulted in embryonic lethality, presumably due to a role for Adam10 in cardiovesicular development (data not shown). Therefore, further investigation of Adam10 function in DN stage development would require additional strategies other than the use of existing Cre transgenic lines.
Studies outlined above provided both genetic and biochemical evidence that ADAM10 controls Notch1 activation during T cell development. Because the phenotype is resulting from deletion of Adam10 within the T cell lineage, we conclude that cleavage of Notch S2 site is primarily accomplished by ADAM10 expressed on thymocytes instead of thymic stromal cells. Notch1 is one of four Notch genes present in mammals and is also the major Notch gene involved in T cell development in the thymus (15, 16, 27) . The phenotypic similarity between Adam10 conditional knockout and Notch1 conditional knockout mice strongly implies that other Notch genes are less likely to play any major roles within the T cell lineage downstream of Adam10. Our study indicates that the T cell intrinsic interaction between ADAM10 and Notch1 is a critical step in Notch activation during thymocyte development. 
